Pfizer-BioNTech Covid shot cleared for adolescents in US
The Peninsula
Pfizer Inc. and BioNTech SE’s Covid-19 vaccine was cleared for use in younger teens in the US, paving the way for the mass vaccination of middle- and high-school students before the start of summer camps and the next school year.
The Food and Drug Administration said in a statement Monday that it had expanded the shot’s original emergency use authorization to include adolescents 12 to 15 years of age. "It was a relatively straightforward decision,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, at a news conference. The vaccine generated a strong immune response, there were no cases of Covid in the vaccinated group, and there were no signs of any new or worrisome side effects, he said.More Related News